RxDoctor Payments Data

Tianyi Tim Wang, MD

Sports Medicine · Stanford, CANPI 1639469349

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.5%), speaking fees and education — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Arthrex at 40.0% of the total. 2025 is the largest year on record at $98,129, more than ten times the $2,440 reported in 2019. Among sports medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$141,384in general payments, 2019–2025

Across 196 payments — averaging $721.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$57K
  • Joint Restoration Foundation, Inc.$29K
  • Moximed, Inc$23K
  • Miach Orthopaedics, Inc.$14K
  • Evolution Surgical, Inc$10K
  • Linvatec Corporation$3K
  • plus $6K from 14 others
$134,444in research payments, 2019–2025

Across 9 payments — averaging $14,938 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Moximed, Inc$70K
  • Miach Orthopaedics, Inc.$60K
  • Joint Restoration Foundation, Inc.$4K
$26,869in ownership & investment interests, 2019–2025

Across 1 payment — averaging $26,869 each. An ownership or investment interest held by the physician or an immediate family member.

  • Overture Orthopaedics$27K

What the payments were for

  • Consulting fees$68,62549%
  • Speaking & faculty fees$44,12531%
  • Travel & lodging$10,1577%
  • Food & beverage$8,2746%
  • Education$10,1847%
  • Entertainment$190%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex81$56,557
Joint Restoration Foundation, Inc.12$29,004
Moximed, Inc11$23,233
Miach Orthopaedics, Inc.5$13,559
Evolution Surgical, Inc14$10,338
Linvatec Corporation4$2,874
Elevate Surgical Co20$1,460
Bioventus LLC2$1,118
Smith+Nephew13$632
Johnson & Johnson7$624
Impactortho, Inc.4$532
Stryker10$499
Overture Orthopaedics2$187
Vericel Corporation3$159
Cartiheal (2009) LTD.1$146
BREG, Inc1$123
Bodycad USA Corp1$112
Zimmer Biomet3$88
Newclip USA LLC1$70
Suvon Surgical LLC1$69

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$141,384 in reported general payments places this provider in the 90th percentile of 662 sports medicine providers in California.

See all sports medicine providers in California

Medicare billing

Part B allowed, 2024
$98,570
Medicare patients
241
Services billed
1,081

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam24$52

Paid to pharmacies, not to this prescriber.

Other sports medicine in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →